Govt Job for M.Pharm, B.Pharm as Quality Manager at IGIMS – Salary Rs 39,000/- pm

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences, New Delhi. The objective was to provide super specialty medical facilities in Bihar.

On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years. According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS.

Walk-In-Interview for the post of Quality Manager on contractual basis under research project “To Establish Clinical Trial Networks for hospital-based trial in Ophthalmology”.

Post :Quality Manager (01-UR)

Qualification : B.Pharma/M.Pharma preferably with management certified course
Desirable :- Experience in drug trial

Salary : 39,000/month
Age limit : 35 years
Remarks : Relaxation of age as per rule prescribed.

Candidates having requisite qualification & experience with a copy of complete BIO-DATA with their original papers and its photocopy with two passport size photographs may come for walk-in interview on date and time mentioned below.

No TA/DA is allowed for appearing in the interview. Director, IGIMS, Patna reserves the right to cancel the recruitment process at any stage without assigning any reason.

A Walk-in interview of eligible Indian Citizen for appointment of above post has been fixed on 10-07-2021 at 10:30 A.M.in the office Chamber of the HOD, RIO, IGIMS, Patna

Related Posts

  • Pharma
  • July 11, 2025
  • 101 views
India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

July:  India’s Glenmark Pharmaceuticals (GLEN.NS), opens new tab said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie (ABBV.N), opens new tab have signed an exclusive licensing agreement…

  • Pharma
  • July 10, 2025
  • 157 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies